Federal regulators have approved Celgene Inc.'s drug Abraxane to treat late-stage pancreatic cancer.
Sep 07, 2013
5 / 5 (2) | 0
(HealthDay)—Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.
Feb 09, 2013
not rated yet | 0